skip to Main Content


In addition to developing the Rome Criteria for diagnosing Functional GI Disorders (FGIDs), the Rome Foundation appoints working teams that address other complex issues in the field. In choosing team members, the Board has selected senior-level members internationally who are directly involved in and who have published in the topic areas chosen by the Board. The purpose of these working team committees is to develop a summary of the research and literature to date and then offer guidelines or recommendations to help advance future research. The teams would then develop a manuscript to be published in a peer-reviewed journal.

Standing Committees

Active Working Teams

Completed Working Teams

Post Infection IBS 

Giovanni Barbara, MD, Chair       
Madhusudan Grover, MD, Co-Chair

Brain Imaging in DGBI

Emeran A. Mayer, MD, Chair        
Qasim Aziz PhD, Co-Chair

Neuromodulators for FGIDs

Douglas Drossman, MD, Chair       
Jan Tack, MD, PhD, Co-Chair

Pharmacological Trials in Children with Constipation

Miguel Saps, MD, Chair

Multinational Cross-Cultural Research

Ami Sperber, MD, MSPH, Chair

Pharmacological Trials in Children with IBS

Miguel Saps, MD, Chair

Asian Working Teams for FGIDs

Kok Ann, Gwee MD, PhD, Chair
William E. Whitehead, PhD, Co-Chair

Primary Care in FGIDs

A. P. Hungin, MD, Chair
Joel Heidelbaugh, MD, Co-Chair

Food and Diet

William D. Chey, MD, Chair
Jan Tack, MD, PhD, Co-Chair

Role of Intestinal Flora in FGIDs

Magnus Simrén, MD, PhD, Chair
Giovanni Barbara, MD, Co-Chair

Guidelines for Severity in IBS

Douglas Drossman, MD, Chair
Lin Chang, MD, Co-Chair

Guidelines for Brain Imaging in the FGIDs

Emeran A. Mayer, MD, Chair
Qasim Aziz, MD, PhD, Co-Chair

Outcomes/Endpoints in Pharmaceutical Clinical Trials

Michael Camilleri, MD, Chair

Rome IV Committee

Rome IV: The Functional Gastrointestinal Disorders: Disorders of Gut-Brain Interaction. Through the work of 6 editors, 117 authors from 23 countries on 18 committees, and our administrative staff, Rome IV provides the culmination of a 5-year process with updates in the criteria with 19 chapters that address the organ-based criteria, basic science, physiology, pharmacology & pharmacokinetics, psychosocial aspects, gender, age, society, culture, and the patient’s perspective, design of treatment trials, and development and validation of the Rome IV diagnostic questionnaire.
Herein is a list of the members whose knowledge, experience, and hard work led to this final product.

Back To Top